Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Company is developing bespoke radiopharmaceuticals with capital efficient and rapid approachProceeds to support progression of five candidates int...